Rocket One (RKTO) Interest & Investment Income (2022 - 2026)
Rocket One's (RKTO) quarterly Interest & Investment Income came in at $149.0 in Q2 2026, down 13.87% year-over-year from $173.0 in Q2 2025, and down 13.87% quarter-over-quarter from $173.0 in Q2 2025.
Analysis
Rocket One (RKTO) Interest & Investment Income (2022 - 2026) Analysis & Trends
Rocket One has disclosed Interest & Investment Income across 4 years of filings, most recently posting $149.0 for Q2 2026.
- In Q2 2026, Interest & Investment Income fell 13.87% year-over-year to $149.0; the TTM figure through Jun 2026 stood at $53988.0 (changed N/A YoY), while the FY2023 annual figure was $781.0, down 87.74% from the prior year.
- Interest & Investment Income came in at $149.0 for Q2 2026 at Rocket One, down from $173.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $28113.0 in Q1 2023 to a low of $149.0 in Q2 2026.
- Average Interest & Investment Income over 4 years is $13497.0, with a median of $12863.0 recorded in 2022.
- Year-over-year, Interest & Investment Income advanced 10.02% in 2023 and retreated 13.87% in 2026.
- Over 4 years, Interest & Investment Income stood at $25553.0 in 2022, then rose by 10.02% to $28113.0 in 2023, then plunged by 99.38% to $173.0 in 2025, then slipped by 13.87% to $149.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $149.0 in Q2 2026, $173.0 in Q2 2025, and $28113.0 in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 120.60 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | -48.00 Mn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | 48.00 Mn |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | 67.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | 36.92 Mn |
| 10 | Rocket One | 13.80 Mn | 5.90 Mn | - | 149.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 149.00 |
| Jun 30, 2025 | 173.00 |
| Mar 31, 2023 | 28,113.00 |
| Mar 31, 2022 | 25,553.00 |